ISRG,CAMP Stock Price and Quote

Peers: MDT SYK ABT BSX EW BDX ZBH BAX TFX MDLN

| Held by: VTI VOO QQQ IVV SPY VUG XLV QQQM IWF IHI

Index	NDX, S&P 500
Market Cap	134.42B
Enterprise Value	129.31B
Income	3.14B
Sales	11.03B
Book/sh	51.34
Cash/sh	14.85
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	17021
IPO	Jun 13, 2000

P/E	43.61
Forward P/E	31.50
PEG	2.09
P/S	12.18
P/B	7.41
P/C	25.62
P/FCF	41.71
EV/EBITDA	30.90
EV/Sales	11.72
Quick Ratio	3.91
Current Ratio	4.96
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	8.73
EPS next Y	12.08
EPS next Q	2.64
EPS this Y	20.93%
EPS next Y	11.87%
EPS next 5Y	15.06%
EPS past 3/5Y	29.18% 21.79%
Sales past 3/5Y	17.39% 18.22%
EPS Y/Y TTM	21.06%
Sales Y/Y TTM	20.66%
EPS Q/Q	26.62%
Sales Q/Q	18.54%
Earnings	Jul 16 AMC
EPS/Sales Surpr.	11.50% 2.37%

Insider Own	0.70%
Insider Trans	-0.80%
Inst Own	89.63%
Inst Trans	0.12%
ROA	15.30%
ROE	17.43%
ROIC	17.28%
Gross Margin	66.66%
Oper. Margin	31.28%
Profit Margin	28.45%
SMA20	2.52%
SMA50	1.95%
SMA200	-16.38%
Trades

Shs Outstand	353.90M
Shs Float	350.81M
Short Float	2.20%
Short Ratio	2.53
Short Interest	7.73M
52W High	603.88 -36.99%
52W Low	328.57 15.80%
Volatility	2.56% 3.06%
ATR (14)	11.08
RSI (14)	53.91
Beta	1.47
Rel Volume	3.11
Avg Volume	3.05M
Volume	474,497

Perf Week	3.07%
Perf Month	-4.33%
Perf Quarter	-6.46%
Perf Half Y	-20.72%
Perf YTD	-32.82%
Perf Year	-12.70%
Perf 3Y	27.61%
Perf 5Y	10.05%
Perf 10Y	398.93%
Recom	1.76
Target Price	479.86
Prev Close	383.54
Price	380.50
Change %	-0.79%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-12-26	Upgrade	Oppenheimer	Perform → Outperform	$500
Jul-30-26	Downgrade	HSBC Securities	Buy → Hold	$391
Jul-28-26	Initiated	UBS	Buy	$500
Jul-09-26	Initiated	BMO Capital Markets	Outperform	$518
Mar-11-26	Upgrade	Citigroup	Neutral → Buy	$590
Jan-27-26	Initiated	TD Cowen	Buy	$660
Dec-11-25	Downgrade	Citigroup	Buy → Neutral	$635
Jul-23-25	Downgrade	Erste Group	Buy → Hold
Jun-09-25	Downgrade	Deutsche Bank	Hold → Sell	$440
Jun-05-25	Upgrade	Erste Group	Hold → Buy
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$522 → $650
Aug-02-24	Upgrade	Redburn Atlantic	Neutral → Buy	$380 → $510
Jul-10-24	Reiterated	Citigroup	Buy	$462 → $512
May-30-24	Initiated	Goldman	Buy	$500
Nov-17-23	Initiated	HSBC Securities	Buy	$318
Jul-19-23	Initiated	Robert W. Baird	Outperform	$377
Apr-19-23	Reiterated	Wells Fargo	Overweight	$289 → $310
Apr-19-23	Reiterated	Truist	Buy	$300 → $325
Apr-19-23	Reiterated	Stifel	Buy	$285 → $315
Apr-19-23	Reiterated	RBC Capital Mkts	Outperform	$305 → $309

Show Previous Ratings

Today 08:33AM	Can Intuitive Surgical Make Up For A Lower Price Per Surgery? (Trefis)
Sep-17-26 03:06PM	Is ISRG Stock Really As Expensive As It Looks? (Trefis)
Sep-14-26 10:34AM	Get Paid To Wait For ISRG Stock To Go On Sale (Trefis)
02:00AM	Intuitive announces expanded indication for da Vinci SP in Europe (PR Newswire)
Sep-11-26 11:37AM	Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet (Quartz)
04:22PM	Loading…
Sep-09-26 04:22PM	How Much Can ISRG Stock Still Move Against You? (Trefis)
Sep-08-26 04:05PM	New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions (GlobeNewswire)
Sep-02-26 03:37PM	ISRG Stock: The Best House On The Block Costs The Most (Trefis)
Aug-27-26 08:12PM	Can ISRG Stock Defend Its $131B Valuation? (Trefis)
Aug-25-26 07:08PM	Can These Beaten Down Stocks Bounce Back? (Zacks)
03:30PM	Eli Lilly Is Pulling Away From the Rest of Healthcare (GuruFocus.com)
11:08AM	The Hospital Bet That Reframes The Intuitive Surgical Stock Story (Trefis)
Aug-21-26 02:01PM	Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening (Trefis)
Aug-20-26 04:30PM	Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors (MarketWatch) -5.84%
Aug-14-26 05:54PM	Which Medtech Giant Would Buy Inspire Medical Systems? (Trefis)
05:37PM	Loading…
Aug-12-26 05:37PM	The Paid-To-Hold Play On ISRG Stock: A 12% Annualized Income (Trefis)
01:20PM	Two Years Of Growth Barely Change What You Pay For Intuitive Surgical (Trefis)
08:59AM	Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out" (Investing.com)
08:25AM	Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall (GuruFocus.com)
Aug-03-26 04:30PM	Intuitive Surgical Inc. stock outperforms competitors on strong trading day (MarketWatch) +6.25%
02:17AM	FTSE 100 Live: London lagging as AstraZeneca plunges and commodities slip (Proactive)
Jul-29-26 09:46AM	The Best House On The Block Costs The Most: ISRG (Trefis)
07:13AM	GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds (Reuters)
Jul-28-26 09:34AM	Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls (The Fly)
09:27AM	UBS starts medtech coverage, favors Intuitive Surgical and Enovis (Investing.com)
Jul-27-26 04:30PM	Intuitive Surgical Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.73%
09:15AM	Intuitive Collaborates with Deion "Coach Prime" Sanders to Raise Patient Awareness of Surgical Options (GlobeNewswire)
Jul-24-26 08:47AM	Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing? (Trefis)
08:25AM	6 Medical-Device Stocks to Buy After a Massive Selloff (Barrons.com)
01:30AM	Medical-Device Stocks Are in the Bargain Bin. 6 to Buy. (Barrons.com)
09:05AM	Loading…
Jul-23-26 09:05AM	Intuitive Shares Vision for an AI-Enabled Future of Healthcare (GlobeNewswire)
Jul-22-26 11:31PM	Why Did PEGA, ISRG, MCD Stocks Plunge To 52-Week Lows Today? (Stocktwits)
07:21AM	J&J enters US robotic surgery market after device gets marketing authorization (Reuters)
Jul-21-26 02:43PM	ISRG Stock: The Math Hidden In Its Price (Trefis)
08:22AM	Nvidia Returns to NZS Growth Fund (GuruFocus.com)
Jul-20-26 03:15PM	The Robot Maker's Paradox (Trefis)
02:21PM	What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth? (Trefis)
Jul-18-26 09:02AM	ROBO's Dip History Offers A Cautious Green Light (Trefis)
Jul-17-26 04:30PM	Intuitive Surgical Inc. stock underperforms Friday when compared to competitors (MarketWatch) -14.15%
04:15PM	Why Intuitive Surgical Stock Plunged Today (Investopedia)
04:00PM	Intuitive Surgical Falls to a 52-Week Low After Beat (GuruFocus.com)
12:52PM	Why Intuitive Surgical Stock Is Tanking Today (GuruFocus.com)
10:38AM	Intuitive Surgical shares fall as procedure growth slows despite Q2 earnings beat (Proactive)
09:47AM	ISRG Stock Gets A Barrage Of Price Target Cuts From Wall Street Citi Removes It From Upside 90-Day Catalyst Watch (Stocktwits)
08:34AM	Netflix, Intuitive Surgical tumble premarket (Investing.com)
07:53AM	Why This Surgical Robot Stock Is Still a Buy During Its Worst Day in 4 Years (Barrons.com)
06:13AM	Intuitive Surgical shares slide despite earnings beat as 2026 outlook underwhelms (InvestorsHub)
06:13AM	Intuitive Surgical shares slide despite earnings beat as 2026 outlook underwhelms (ECO) (InvestorsHub)
Jul-16-26 04:05PM	Intuitive Announces Second Quarter Earnings (GlobeNewswire)
09:59AM	Why Abbott Stock Is Reimagining Its Future (Trefis)
05:03AM	Netflix earnings on tap after rough period for the streaming company's stock (MarketWatch)
Jul-15-26 02:33PM	The Open Questions On ISRG Stock (Trefis)
Jul-14-26 04:30PM	Intuitive Surgical Inc. stock underperforms Tuesday when compared to competitors (MarketWatch) -6.78%
02:06PM	The Paid-To-Hold Play On ISRG Stock: A 12% Income (Trefis)
08:52AM	ISRG Stock: What Does Its Valuation Imply? (Trefis)
Jul-10-26 07:04AM	Medicaroid wins Europes CE mark for Hinotori surgical robot (MedTech Dive)
Jul-09-26 09:29AM	Just How Much Risk Is Built Into ISRG Stock? (Trefis)
Jul-08-26 12:41PM	Just How Wide Is The Path Ahead For Intuitive Surgical Stock? (Trefis)
Jul-07-26 09:22AM	How To Target A 10% Yield While Catching The BSX Stock Knife? (Trefis)
Jul-06-26 11:31AM	Intuitive Surgical Stock Looks Weighed Down. Its After-Hours Growth Says Otherwise. (Trefis)
Jun-23-26 02:11PM	The Cash-Flow Fortress The Stryker Stock Bears Keep Missing (Trefis)
Jun-18-26 07:01AM	This Undervalued Medical-Devices Stock Is Poised for a Rebound (Barrons.com)
Jun-04-26 06:00AM	Medtronic seeks clearance for Hugo surgical robot in more indications (MedTech Dive)
May-28-26 04:30PM	Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton (GlobeNewswire)
08:03AM	BSX Stock: Don't Try To Catch The Falling Knife (Trefis)
May-21-26 09:15AM	Intuitive Announces Innovations to Advance Quintuple Aim (GlobeNewswire)
May-19-26 11:52AM	Is BSX Stock A Value Trap Or A Rebound Play? (Trefis)
May-11-26 04:30PM	Intuitive Surgical Inc. stock underperforms Monday when compared to competitors (MarketWatch) -6.67%
Apr-24-26 07:00AM	J&J lands CE mark for surgical stapler that works with Ottava robot (MedTech Dive)
Apr-23-26 11:54AM	Why BSX Stock's Q1 Beat Is A Lagging Indicator (Trefis)
Apr-22-26 01:13PM	Intuitive Surgical Jumps 7% on Earnings Beat and Raised Full-Year Outlook (GuruFocus.com) +7.16%
12:47PM	Intuitive Surgical Q1 results top estimates as robotic surgery demand accelerates (Proactive)
11:28AM	How ISRG Just Secured The U.S. Market (Trefis)
03:04AM	Intuitive Surgical Inc (ISRG) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... (GuruFocus.com)
Apr-21-26 05:14PM	Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies (Barrons.com)
04:38PM	Intuitive Announces First Quarter Earnings (GlobeNewswire)
Apr-09-26 08:11PM	Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation? (Quartz)
Apr-08-26 09:31AM	Tired of AI and Oil? Buy the Robot. (Trefis)
Apr-03-26 07:38AM	Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments (MedTech Dive)
Mar-31-26 06:30AM	Can Boston Scientific Stock Surge 40% From Here? (Trefis)
Mar-24-26 11:03AM	Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems (PR Newswire)
Mar-23-26 01:01AM	ISRG- Not Cheap, But Delivering on Growth Expectations (MoneyShow)
Mar-13-26 02:38PM	Intuitive Surgical Stock Falls After Cybersecurity Breach Hits Internal Systems (GuruFocus.com)
11:47AM	Intuitive Surgical hit by phishing incident (MedTech Dive)
Mar-11-26 09:40AM	Oracle, Nike upgraded: Wall Street's top analyst calls (The Fly)
07:45AM	Here Are Wednesday's Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More (24/7 Wall St.)
05:20AM	Citi upgrades Intuitive Surgical to Buy on recent selloff (TipRanks)
05:10AM	Intuitive Surgical upgraded to Buy from Neutral at Citi (TipRanks)
Mar-10-26 01:39PM	Stryker Introduces SmartHospital Platform to Advance Connected Care (Zacks)
01:11PM	GEHC Wins FDA 510(k) Approval for View, Enhances Radiology Workflows (Zacks)
10:55AM	Here's Why You Should Retain CONMED Stock in Your Portfolio Now (Zacks)
09:34AM	5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside (Zacks)
09:05AM	National Vision Gains 129.5% in a Year: What's Driving the Rally? (Zacks)
08:24AM	Should You Continue to Hold DGX Stock in Your Portfolio? (Zacks)
05:36AM	Intuitive Surgical, Inc. (ISRG) Announces the Completion of its Acquisition of the da Vinci and Ion Distribution Business (Insider Monkey)
02:48AM	SS Innovations raises $18.6M as surgical robot nears US market (MedTech Dive)
Mar-09-26 01:03PM	IDEXX Laboratories Stock Climbs 39.4% in a Year: What's Driving It? (Zacks)
11:53AM	Novocure's Optune Lua Gets Japan Reimbursement for NSCLC Treatment (Zacks)
09:30AM	Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
12:43AM	2 Healthcare Stocks with Exciting Potential and 1 We Avoid (StockStory)

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

CEODave Rosa Rosa

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Widman Fredrik	VP Corporate Controller	Sep 15 '26	Option Exercise	94.52	1,089	102,933	1,572	Sep 16 01:35 PM
Widman Fredrik	VP Corporate Controller	Sep 15 '26	Sale	374.44	1,089	407,765	1,026	Sep 16 01:35 PM
FREDRIK WIDMAN	Officer	Sep 15 '26	Proposed Sale	377.94	2,178	823,153		Sep 15 04:43 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Sep 11 '26	Sale	365.79	25	9,145	764	Sep 11 06:41 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Sep 10 '26	Sale	347.66	23	7,996	789	Sep 11 06:41 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Sep 08 '26	Sale	361.23	46	16,617	835	Sep 09 06:45 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Sep 09 '26	Sale	350.20	23	8,055	812	Sep 09 06:45 PM
MARK BROSIUS	Officer	Sep 08 '26	Proposed Sale	366.70	694	254,490		Sep 08 04:29 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 20 '26	Sale	396.37	77	30,520	958	Aug 21 07:56 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 21 '26	Sale	375.57	77	28,919	881	Aug 21 07:56 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 19 '26	Sale	394.26	77	30,358	1,035	Aug 19 05:39 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 18 '26	Sale	394.00	77	30,338	1,112	Aug 19 05:39 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Aug 17 '26	Sale	390.67	77	30,082	1,189	Aug 19 05:39 PM
GUTHART GARY S	Director	Aug 11 '26	Sale	400.00	10,000	4,000,000	1,245,679	Aug 12 01:22 PM
Ladd Amy L	Director	Aug 10 '26	Sale	379.00	400	151,600	251	Aug 11 05:55 PM
Ladd Amy L	Director	Aug 11 '26	Sale	393.10	72	28,303	179	Aug 11 05:55 PM
GUTHART FAMILY TRUST	Director	Aug 11 '26	Proposed Sale	393.38	20,095	7,904,971		Aug 11 04:28 PM
LOEB GARY	EVP & Chief Legal and Complian	Aug 10 '26	Sale	379.00	400	151,600	5,320	Aug 10 05:55 PM
AMY L LADD	Director	Aug 10 '26	Proposed Sale	378.81	472	178,798		Aug 10 04:32 PM
GARY LOEB	Officer	Aug 10 '26	Proposed Sale	378.81	400	151,524		Aug 10 04:31 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 31 '26	Sale	351.00	28	9,828	1,266	Jul 31 05:59 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 30 '26	Sale	346.83	28	9,711	1,294	Jul 31 05:59 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 28 '26	Sale	365.58	28	10,236	1,350	Jul 29 05:31 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 29 '26	Sale	360.21	28	10,086	1,322	Jul 29 05:31 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jul 27 '26	Sale	344.00	28	9,632	1,378	Jul 29 05:31 PM
Rosa David J.	Chief Executive Officer (CEO)	Jul 10 '26	Option Exercise	0.00	1,910	0	247,803	Jul 13 05:54 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 12 '26	Sale	414.13	25	10,353	1,406	Jun 12 06:29 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 11 '26	Sale	412.16	23	9,480	1,431	Jun 12 06:29 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 10 '26	Sale	424.14	23	9,755	1,454	Jun 10 06:01 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 09 '26	Sale	421.13	23	9,686	1,477	Jun 10 06:01 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	Jun 08 '26	Sale	420.12	23	9,663	1,500	Jun 10 06:01 PM
LOEB GARY	EVP & Chief Legal and Complian	Jun 10 '26	Sale	424.14	400	169,656	5,720	Jun 10 05:51 PM
GARY LOEB	Officer	Jun 10 '26	Proposed Sale	426.61	400	170,644		Jun 10 04:28 PM
Rosa David J.	Chief Executive Officer (CEO)	Jun 10 '26	Option Exercise	0.00	1,358	0	246,567	Jun 10 01:24 PM
MARK BROSIUS	Officer	Jun 08 '26	Proposed Sale	422.06	665	280,670		Jun 08 04:38 PM
AMAL JOHNSON	Director	Jun 03 '26	Proposed Sale	402.30	12,472	5,017,486		Jun 03 04:27 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Jun 01 '26	Option Exercise	77.00	5,625	433,119	12,088	Jun 02 10:08 AM
Jeddi Iman	SVP & GM da Vinci Platforms &	Jun 01 '26	Sale	420.55	5,625	2,365,594	6,463	Jun 02 10:08 AM
IMAN JEDDI	Officer	Jun 01 '26	Proposed Sale	420.55	5,625	2,365,594		Jun 01 04:06 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 21 '26	Sale	446.04	18	8,029	1,541	May 22 08:09 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 22 '26	Sale	439.80	18	7,916	1,523	May 22 08:09 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 19 '26	Sale	440.70	18	7,933	1,577	May 20 06:02 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 20 '26	Sale	440.38	18	7,927	1,559	May 20 06:02 PM
Brosius Mark	EVP & Chief Mfg and Supply Cha	May 18 '26	Sale	422.47	18	7,604	1,595	May 20 06:02 PM
LOEB GARY	EVP & Chief Legal and Complian	May 11 '26	Sale	446.95	400	178,780	6,120	May 11 07:11 PM
GARY LOEB	Officer	May 11 '26	Proposed Sale	450.06	400	180,024		May 11 04:35 PM
Reed Monica P	Director	Apr 30 '26	Option Exercise	0.00	531	0	2,876	Apr 30 09:13 PM
NACHTSHEIM JAMI K	Director	Apr 30 '26	Option Exercise	0.00	531	0	6,902	Apr 30 09:07 PM
Leonard Keith R	Director	Apr 30 '26	Option Exercise	0.00	531	0	901	Apr 30 09:02 PM
Ladd Amy L	Director	Apr 30 '26	Option Exercise	0.00	531	0	651	Apr 30 08:56 PM
Kolli Sreelakshmi	Director	Apr 30 '26	Option Exercise	0.00	531	0	1,510	Apr 30 08:51 PM
Johnson Amal M	Director	Apr 30 '26	Option Exercise	0.00	531	0	13,545	Apr 30 08:44 PM
CHEW LEWIS	Director	Apr 30 '26	Option Exercise	0.00	531	0	1,314	Apr 30 08:36 PM
Beery Joseph C	Director	Apr 30 '26	Option Exercise	0.00	531	0	3,641	Apr 30 08:21 PM
BARRATT CRAIG H	Director	Apr 30 '26	Option Exercise	0.00	750	0	27,948	Apr 30 08:12 PM
Ladd Amy L	Director	Apr 28 '26	Sale	473.46	500	236,730	239	Apr 29 05:38 PM
Ladd Amy L	Director	Apr 29 '26	Sale	463.50	119	55,156	120	Apr 29 05:38 PM
AMY LADD	Director	Apr 28 '26	Proposed Sale	470.99	619	291,543		Apr 28 04:31 PM
MCADAMS FAMILY REVOCABLE LIVIN	Former Officer	Apr 27 '26	Proposed Sale	470.91	30,417	14,323,761		Apr 27 04:37 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 10 '26	Option Exercise	229.39	105	24,086	105	Mar 11 01:46 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 10 '26	Sale	493.95	105	51,865	0	Mar 11 01:46 PM
MYRIAM CURET MCADAMS	Officer	Mar 10 '26	Proposed Sale	493.95	105	51,865		Mar 10 04:47 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 06 '26	Sale	490.19	648	317,643	2,258	Mar 10 02:24 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 09 '26	Sale	485.01	645	312,831	1,613	Mar 10 02:24 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 04 '26	Sale	498.68	2,362	1,177,883	3,554	Mar 05 06:38 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 05 '26	Sale	495.20	648	320,890	2,906	Mar 05 06:38 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 03 '26	Sale	488.10	648	316,289	5,916	Mar 05 06:38 PM
MARK BROSIUS	Officer	Mar 05 '26	Proposed Sale	501.18	1,714	859,023		Mar 05 04:43 PM
BRIAN MILLER	Officer	Mar 04 '26	Proposed Sale	497.42	8,368	4,162,411		Mar 04 04:43 PM
Widman Fredrik	VP Corporate Controller	Feb 28 '26	Option Exercise	0.00	468	0	1,377	Mar 03 06:17 PM
Widman Fredrik	VP Corporate Controller	Feb 27 '26	Sale	499.71	249	124,428	909	Mar 03 06:17 PM
Widman Fredrik	VP Corporate Controller	Mar 03 '26	Sale	487.18	118	57,487	1,026	Mar 03 06:17 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 02 '26	Option Exercise	208.90	125	26,112	5,262	Mar 03 05:34 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 03 '26	Sale	487.18	4,728	2,303,387	409	Mar 03 05:34 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 02 '26	Sale	492.59	125	61,574	5,137	Mar 03 05:34 PM
MARK BROSIUS	Officer	Mar 03 '26	Proposed Sale	496.25	3,327	1,651,024		Mar 03 04:32 PM
FREDRIK WIDMAN	Officer	Mar 03 '26	Proposed Sale	487.18	118	57,487		Mar 03 04:29 PM
MYRIAM CURET MCADAMS	Officer	Mar 03 '26	Proposed Sale	487.18	4,728	2,303,387		Mar 03 04:17 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 28 '26	Option Exercise	0.00	9,004	0	10,618	Mar 03 12:53 PM
GUTHART GARY S	Director	Feb 28 '26	Option Exercise	0.00	28,840	0	36,848	Mar 03 12:25 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 28 '26	Option Exercise	0.00	11,525	0	20,709	Mar 02 07:41 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 28 '26	Option Exercise	0.00	3,148	0	8,082	Mar 02 06:40 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 28 '26	Option Exercise	0.00	11,525	0	16,410	Mar 02 05:17 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 28 '26	Option Exercise	0.00	24,918	0	249,698	Mar 02 05:02 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 28 '26	Option Exercise	0.00	9,255	0	10,719	Mar 02 04:48 PM
MYRIAM CURET MCADAMS	Officer	Mar 02 '26	Proposed Sale	492.59	125	61,574		Mar 02 04:09 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 28 '26	Option Exercise	0.00	9,380	0	9,292	Mar 02 03:41 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 27 '26	Sale	499.71	2,345	1,171,820	409	Mar 02 03:41 PM
WADORS PATRICIA L	SVP Chief Human Resources Offi	Feb 26 '26	Option Exercise	0.00	458	0	458	Feb 27 06:43 PM
WADORS PATRICIA L	SVP Chief Human Resources Offi	Feb 27 '26	Sale	499.71	220	109,936	0	Feb 27 06:43 PM
FREDRIK WIDMAN	Officer	Feb 27 '26	Proposed Sale	499.71	249	124,428		Feb 27 04:24 PM
MYRIAM CURET MCADAMS	Officer	Feb 27 '26	Proposed Sale	499.71	2,345	1,171,820		Feb 27 04:11 PM
PATRICIA WADORS	Officer	Feb 27 '26	Proposed Sale	499.71	220	109,936		Feb 27 04:09 PM
Jeddi Iman	SVP & GM da Vinci Platforms &	Feb 26 '26	Option Exercise	0.00	2,309	0	2,263	Feb 27 03:04 PM
Charlton Henry L	EVP & Chief Commercial and Mkt	Feb 26 '26	Option Exercise	0.00	2,747	0	5,679	Feb 27 02:53 PM
Samath Jamie	EVP & CFO & Enterprise Technol	Feb 26 '26	Option Exercise	0.00	3,396	0	10,295	Feb 27 02:45 PM
LOEB GARY	EVP & Chief Legal and Complian	Feb 26 '26	Option Exercise	0.00	2,442	0	5,389	Feb 27 02:36 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 26 '26	Option Exercise	0.00	4,654	0	3,549	Feb 27 02:00 PM
Widman Fredrik	VP Corporate Controller	Feb 26 '26	Option Exercise	0.00	989	0	1,346	Feb 27 01:52 PM
Rosa David J.	Chief Executive Officer (CEO)	Feb 26 '26	Option Exercise	0.00	6,105	0	233,783	Feb 27 01:42 PM

CAMP CAMP4 Therapeutics Corp daily Stock Chart

Peers: OABI HUMA RNA TNXP UNCY WHWK MIST CNTX TENX KPTI

| Held by: VTI IWM VXF IWO VTWO IWC BUSM GSSC VTWG RSSL

Index	RUT
Market Cap	253.21M
Enterprise Value	168.45M
Income	-107.24M
Sales	4.22M
Book/sh	-0.01
Cash/sh	1.39
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	48
IPO	Oct 11, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	60.00
P/B	-
P/C	2.91
P/FCF	-
EV/EBITDA	-
EV/Sales	39.92
Quick Ratio	4.70
Current Ratio	4.70
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-2.23
EPS next Y	-0.73
EPS next Q	-0.17
EPS this Y	58.46%
EPS next Y	33.24%
EPS next 5Y	35.01%
EPS past 3/5Y	-5.31% -
Sales past 3/5Y	- -
EPS Y/Y TTM	13.40%
Sales Y/Y TTM	40.21%
EPS Q/Q	7.30%
Sales Q/Q	18.84%
Earnings	Aug 13 AMC
EPS/Sales Surpr.	-174.36% 9.81%

Insider Own	47.77%
Insider Trans	-1.79%
Inst Own	53.35%
Inst Trans	4.64%
ROA	-148.23%
ROE	-545.85%
ROIC	-12228.51%
Gross Margin	57.12%
Oper. Margin	-1242.50%
Profit Margin	-2543.74%
SMA20	-3.79%
SMA50	-1.48%
SMA200	-10.59%
Trades

Shs Outstand	51.93M
Shs Float	32.77M
Short Float	3.62%
Short Ratio	4.33
Short Interest	1.19M
52W High	7.75 -47.94%
52W Low	2.20 83.41%
Volatility	8.66% 8.46%
ATR (14)	0.35
RSI (14)	45.88
Beta	0.26
Rel Volume	1.55
Avg Volume	274.38K
Volume	21,211

Perf Week	-5.06%
Perf Month	-13.23%
Perf Quarter	-2.30%
Perf Half Y	-21.80%
Perf YTD	-34.18%
Perf Year	61.40%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	9.50
Prev Close	4.03
Price	4.03
Change %	0.12%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-26	Upgrade	JP Morgan	Neutral → Overweight	$9
Jun-10-26	Initiated	Chardan Capital Markets	Buy	$6.50
Apr-14-26	Initiated	Rodman & Renshaw	Buy	$7
Oct-02-25	Initiated	Cantor Fitzgerald	Overweight	$7
Sep-16-25	Downgrade	JP Morgan	Overweight → Neutral
May-27-25	Initiated	Wedbush	Outperform	$8
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	Piper Sandler	Overweight	$18
Nov-05-24	Initiated	JP Morgan	Overweight	$23

Sep-10-26 07:33AM	CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder (GlobeNewswire)
Sep-08-26 04:05PM	CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026 (GlobeNewswire)
Sep-01-26 04:05PM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-13-26 04:05PM	CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights (GlobeNewswire) +20.89%
Aug-04-26 07:00AM	CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement (GlobeNewswire)
07:00AM	Loading…
Jul-27-26 07:00AM	CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder (GlobeNewswire) +8.23%
Jul-17-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -10.51%
Jun-19-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-21-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-14-26 07:00AM	CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder (GlobeNewswire)
May-07-26 04:05PM	CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights (GlobeNewswire) +6.90%
Apr-28-26 08:00AM	CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation (GlobeNewswire)
Apr-17-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-24-26 07:00AM	CAMP4 Appoints Michael MacLean to its Board of Directors (GlobeNewswire)
Mar-06-26 04:05PM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire) -8.50% +49.40%
04:05PM	Loading…
Mar-05-26 04:05PM	CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights (GlobeNewswire) +12.50%
Feb-20-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-16-26 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -21.00%
Jan-13-26 12:00PM	CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why (Zacks)
Jan-06-26 08:00AM	CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-02-26 03:22PM	Getty Images, Torm, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-19-25 06:01AM	Novo files for CagriSema approval; Merck and Pfizers trial win (BioPharma Dive)
Dec-18-25 07:10AM	CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock (GlobeNewswire) -12.90%
07:00AM	CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries (GlobeNewswire)
Dec-12-25 04:05PM	CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.99%
Nov-14-25 04:05PM	CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-06-25 04:05PM	CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.97%
Oct-14-25 02:09PM	3 Healthcare Companies Insiders Are Buying (MarketBeat) -6.63%
Oct-01-25 08:00AM	CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 (GlobeNewswire)
Sep-25-25 12:00PM	CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know (Zacks) +7.53%
09:40AM	Loading…
Sep-17-25 09:40AM	Apple initiated, Hershey upgraded: Wall Streets top analyst calls (TipRanks) -6.50%
Sep-16-25 09:35AM	Apple initiated, Hershey upgraded: Wall Street's top analyst calls (The Fly)
Sep-10-25 07:00AM	CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders (GlobeNewswire) +40.20%
Aug-14-25 04:05PM	CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) +6.16% +7.74%
Jun-30-25 08:00AM	Sequans Appoints Jason W. Cohenour to Board of Directors (Newsfile)
May-16-25 06:00AM	CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) +9.52%
May-13-25 04:05PM	CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights (GlobeNewswire) -7.92%
Apr-28-25 04:30PM	CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting (GlobeNewswire) -10.00% -5.15%
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Mar-27-25 04:05PM	CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -10.16%
Mar-18-25 08:00AM	CAMP4 Appoints Multiple Industry Veterans to its Board of Directors (GlobeNewswire)
Mar-04-25 05:24AM	CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey) -5.27%
Feb-06-25 08:00AM	CAMP4 to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.95%
Jan-13-25 08:00AM	CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-07-25 04:05PM	CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones (GlobeNewswire)
Dec-10-24 08:00AM	CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors (GlobeNewswire) -8.08%
Dec-02-24 08:00AM	CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +5.85%
Nov-21-24 04:05PM	CAMP4 Reports Third Quarter 2024 Financial Results (GlobeNewswire) +8.44% -6.40%
Oct-10-24 07:07PM	CAMP4 Announces Pricing of Initial Public Offering (GlobeNewswire)

CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

MBAJosh Mandel-Brehm

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gold Kelly	Chief Financial Officer	Aug 31 '26	Buy	3.96	10,000	39,600	10,000	Sep 02 07:50 PM
Schwab Andrew J.	Director	Aug 27 '26	Sale	4.04	400,000	1,616,000	2,033,270	Aug 31 05:05 PM
Schwab Andrew J.	Director	Aug 24 '26	Sale	4.50	10	45	2,433,270	Aug 26 04:57 PM
Schwab Andrew J.	Director	Aug 20 '26	Sale	4.54	114,700	520,738	2,465,298	Aug 21 04:59 PM
Schwab Andrew J.	Director	Aug 19 '26	Sale	4.76	45,147	214,900	2,579,998	Aug 21 04:59 PM
Schwab Andrew J.	Director	Aug 21 '26	Sale	4.50	32,018	144,081	2,433,280	Aug 21 04:59 PM
Tardiff Daniel	Chief Scientific Officer	Aug 19 '26	Sale	4.76	1,738	8,273	0	Aug 19 08:46 PM
Daniel Tardiff	affiliate	Aug 19 '26	Proposed Sale	4.76	1,738	8,276		Aug 19 10:23 AM
Young Richard A	Director	Aug 03 '26	Buy	1.65	16,378	27,024	186,388	Aug 05 05:09 PM
Maricich Yuri	Chief Medical Officer	Aug 03 '26	Buy	1.65	6,551	10,809	12,611	Aug 05 05:08 PM
Gold Kelly	Chief Financial Officer	Aug 03 '26	Buy	1.65	6,551	10,809	74,428	Aug 05 05:08 PM
Mandel-Brehm Josh	Chief Executive Officer	Aug 03 '26	Buy	1.65	6,551	10,809	284,968	Aug 05 05:07 PM

ISRG

Intuitive Surgical Inc

CAMP

CAMP4 Therapeutics Corp

Upgrade your Finviz experience